Literature DB >> 33173159

Implications of new genetic risk factors in prion disease.

Sonia M Vallabh1,2,3,4, Eric Vallabh Minikel5,6,7,8.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33173159     DOI： 10.1038/s41582-020-00433-0

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  1 in total

1.  Prion protein lowering is a disease-modifying therapy across prion disease stages, strains and endpoints.

Authors:  Eric Vallabh Minikel; Hien T Zhao; Jason Le; Jill O'Moore; Rose Pitstick; Samantha Graffam; George A Carlson; Michael P Kavanaugh; Jasna Kriz; Jae Beom Kim; Jiyan Ma; Holger Wille; Judd Aiken; Deborah McKenzie; Katsumi Doh-Ura; Matthew Beck; Rhonda O'Keefe; Jacquelyn Stathopoulos; Tyler Caron; Stuart L Schreiber; Jeffrey B Carroll; Holly B Kordasiewicz; Deborah E Cabin; Sonia M Vallabh
Journal:  Nucleic Acids Res       Date:  2020-11-04       Impact factor: 16.971
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.